Dual effect of fetal bovine serum on early development depends on stage-specific reactive oxygen species demands in pigs

PLoS One. 2017 Apr 13;12(4):e0175427. doi: 10.1371/journal.pone.0175427. eCollection 2017.

Abstract

Despite the application of numerous supplements to improve in vitro culture (IVC) conditions of mammalian cells, studies regarding the effect of fetal bovine serum (FBS) on mammalian early embryogenesis, particularly in relation to redox homeostasis, are lacking. Herein, we demonstrated that early development of in vitro-produced (IVP) porcine embryos highly depends on the combination of FBS supplementation timing and embryonic reactive oxygen species (ROS) requirements. Interestingly, FBS significantly reduced intracellular ROS levels in parthenogenetically activated (PA) embryos regardless of the developmental stage. However, the beneficial effect of FBS on early embryogenesis was found only during the late phase (IVC 4-6 days) treatment group. In particular, developmental competence parameters, such as blastocyst formation rate, cellular survival, total cell number and trophectoderm proportion, were markedly increased by FBS supplementation during the late IVC phase. In addition, treatment with FBS elevated antioxidant transcript levels during the late IVC phase. In contrast, supplementation with FBS during the entire period (1-6 days) or during the early IVC phase (1-2 days) greatly impaired the developmental parameters. Consistent with the results from PA embryos, the developmental competence of in vitro fertilization (IVF) or somatic cell nuclear transfer (SCNT) embryos were markedly improved by treatment with FBS during the late IVC phase. Moreover, the embryonic stage-specific effects of FBS were reversed by the addition of an oxidant and were mimicked by treatment with an antioxidant. These findings may increase our understanding of redox-dependent early embryogenesis and contribute to the large-scale production of high-quality IVP embryos.

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Cattle
  • Cloning, Organism / methods
  • Embryo Culture Techniques / methods*
  • Embryo, Mammalian / metabolism*
  • Embryonic Development / drug effects*
  • Parthenogenesis
  • Reactive Oxygen Species / metabolism*
  • Serum*
  • Swine

Substances

  • Antioxidants
  • Reactive Oxygen Species

Grants and funding

This study was supported by grants from the KRIBB Research Initiative Programs (KGM4251723), the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (NRF-2012M3A9B6055362), and the Next-Generation BioGreen 21 Program (PJ0099592016), Rural Development Administration, Republic of Korea.